Noked Israel Ltd 13F annual report

Noked Israel Ltd is an investment fund managing more than $358 million ran by Roy Vermus. There are currently 13 companies in Mr. Vermus’s portfolio. The largest investments include Taiwan Semiconductor Mfg Ltd and Microsoft, together worth $130 million.

$358 million Assets Under Management (AUM)

As of 7th August 2024, Noked Israel Ltd’s top holding is 395,300 shares of Taiwan Semiconductor Mfg Ltd currently worth over $68.7 million and making up 19.2% of the portfolio value. In addition, the fund holds 138,000 shares of Microsoft worth $61.7 million, whose value fell 0.7% in the past six months. The third-largest holding is Alphabet Inc worth $44.1 million and the next is Amazon.com worth $40.4 million, with 209,200 shares owned.

Currently, Noked Israel Ltd's portfolio is worth at least $358 million. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Noked Israel Ltd

The Noked Israel Ltd office and employees reside in Ramat Hasharon, Israel. According to the last 13-F report filed with the SEC, Roy Vermus serves as the Director at Noked Israel Ltd.

Recent trades

In the most recent 13F filing, Noked Israel Ltd revealed that it had opened a new position in Teva Pharmaceutical Inds Ltd and bought 1,685,000 shares worth $27.4 million.

The investment fund also strengthened its position in Taiwan Semiconductor Mfg Ltd by buying 257,300 additional shares. This makes their stake in Taiwan Semiconductor Mfg Ltd total 395,300 shares worth $68.7 million.

On the other hand, there are companies that Noked Israel Ltd is getting rid of from its portfolio. Noked Israel Ltd closed its position in Monday Com Ltd on 14th August 2024. It sold the previously owned 115,500 shares for $26.1 million. Roy Vermus also disclosed a decreased stake in Microsoft by 0.1%. This leaves the value of the investment at $61.7 million and 138,000 shares.

One of the smallest hedge funds

The two most similar investment funds to Noked Israel Ltd are 3d Asset Management, Inc and Ostrum Asset Management U.s. They manage $358 million and $359 million respectively.


Roy Vermus investment strategy

Noked Israel Ltd’s portfolio is diversified across 4 sectors. Currently, their heaviest sector is Technology — making up 47.8% of the total portfolio value. The fund focuses on investments in the United States as 53.8% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up 54% of the total holdings value. On the other hand, small-cap stocks make up only 7.7% of the portfolio. The average market cap of the portfolio companies is close to $653 billion.

The complete list of Noked Israel Ltd trades based on 13F SEC filings

These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security Shares Owned Value Allocation
Taiwan Semiconductor Mfg Ltd
186.45%
395,300
$68,707,000 19.17%
Microsoft Corporation
13.75%
138,000
$61,679,000 17.21%
Alphabet Inc
14.28%
240,200
$44,057,000 12.29%
Amazon.com Inc.
71.19%
209,200
$40,428,000 11.28%
Wix.com Ltd
61.98%
193,000
$30,701,000 8.56%
Teva Pharmaceutical Inds Ltd
Opened
1,685,000
$27,381,000 7.64%
Meta Platforms Inc
18.79%
54,250
$27,354,000 7.63%
Monday Com Ltd
Closed
115,500
$26,088,000
Booking Holdings Inc
21.21%
5,200
$20,600,000 5.75%
CyberArk Software Ltd
Closed
66,400
$17,638,000
Interactive Brokers Group In
91.67%
115,000
$14,099,000 3.93%
Apple Inc
9.06%
60,200
$12,679,000 3.54%
Squarespace, Inc.
Closed
341,500
$12,444,000
Nvdia Corporation
Closed
13,415
$12,121,000
Salesforce Inc
63.86%
30,000
$7,713,000 2.15%
Global E Online Ltd
Closed
150,002
$5,453,000
Alphabet Inc
Closed
29,000
$4,377,000
Spdr S&p 500 Etf Tr
No change
4,794
$2,609,000 0.73%
Camtek Ltd
Closed
15,000
$1,257,000
Palo Alto Networks Inc
Closed
3,100
$881,000
XTL Biopharmaceuticals Ltd.
No change
198,888
$483,000 0.13%
No transactions found
Showing first 500 out of 21 holdings